
Company Number
05406155
Next Accounts
Mar 2026
Shareholders
elysium healthcare limited
Group Structure
View All
Industry
Hospital activities
Registered Address
2 imperial place, maxwell road, borehamwood, hertfordshire, WD6 1JN
Website
www.elysiumhealthcare.co.ukPomanda estimates the enterprise value of ELYSIUM HEALTHCARE PROPERTY 2 LIMITED at £998.8k based on a Turnover of £2.5m and 0.4x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE PROPERTY 2 LIMITED at £7.2m based on an EBITDA of £2.4m and a 3.03x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE PROPERTY 2 LIMITED at £44m based on Net Assets of £17.6m and 2.5x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elysium Healthcare Property 2 Limited is a live company located in borehamwood, WD6 1JN with a Companies House number of 05406155. It operates in the hospital activities sector, SIC Code 86101. Founded in March 2005, it's largest shareholder is elysium healthcare limited with a 100% stake. Elysium Healthcare Property 2 Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.5m with unknown growth in recent years.
Pomanda's financial health check has awarded Elysium Healthcare Property 2 Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
4 Weak
Size
annual sales of £2.5m, make it smaller than the average company (£4m)
£2.5m - Elysium Healthcare Property 2 Limited
£4m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Elysium Healthcare Property 2 Limited
- - Industry AVG
Production
with a gross margin of 19.2%, this company has a higher cost of product (35.3%)
19.2% - Elysium Healthcare Property 2 Limited
35.3% - Industry AVG
Profitability
an operating margin of 86.4% make it more profitable than the average company (11.2%)
86.4% - Elysium Healthcare Property 2 Limited
11.2% - Industry AVG
Employees
with 19 employees, this is below the industry average (55)
- Elysium Healthcare Property 2 Limited
55 - Industry AVG
Pay Structure
on an average salary of £34.9k, the company has an equivalent pay structure (£34.9k)
- Elysium Healthcare Property 2 Limited
£34.9k - Industry AVG
Efficiency
resulting in sales per employee of £131.6k, this is more efficient (£75.7k)
- Elysium Healthcare Property 2 Limited
£75.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Property 2 Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Property 2 Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Property 2 Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Property 2 Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 55.5%, this is a higher level of debt than the average (47.1%)
55.5% - Elysium Healthcare Property 2 Limited
47.1% - Industry AVG
Elysium Healthcare Property 2 Limited's latest turnover from June 2024 is £2.5 million and the company has net assets of £17.6 million. According to their latest financial statements, we estimate that Elysium Healthcare Property 2 Limited has 19 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2,500,000 | 3,750,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,630,000 | 604,000 | 1,679,000 | 2,683,254 | 2,332,856 | 2,074,921 | 3,598,308 | 4,827,393 | 4,856,626 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | 2,159,000 | 3,247,000 | 2,174,000 | 2,174,000 | 2,134,000 | 2,153,000 | 2,223,000 | 417,000 | 1,496,000 | 2,497,544 | 2,147,146 | 1,887,980 | -2,082,548 | 4,647,409 | |
Interest Payable | 755,000 | 1,068,000 | 666,000 | 656,000 | 643,000 | 635,000 | 596,000 | 31,000 | |||||||
Interest Receivable | 503,000 | 25,000 | |||||||||||||
Pre-Tax Profit | 1,404,000 | 2,179,000 | 1,508,000 | 1,518,000 | 1,491,000 | 1,518,000 | 2,130,000 | -1,073,000 | 1,496,000 | 2,497,544 | 2,147,146 | 1,887,980 | -2,082,548 | 4,647,409 | 4,711,732 |
Tax | 5,000 | 6,000 | -859,000 | -285,000 | 359,000 | -366,000 | -1,000 | -2,232,000 | -3,000 | 4,393 | 38,286 | 24,509 | 1,369 | -19,294 | -141,028 |
Profit After Tax | 1,409,000 | 2,185,000 | 649,000 | 1,233,000 | 1,850,000 | 1,152,000 | 2,129,000 | -3,305,000 | 1,493,000 | 2,501,937 | 2,185,432 | 1,912,489 | -2,081,179 | 4,628,115 | 4,570,704 |
Dividends Paid | |||||||||||||||
Retained Profit | 1,409,000 | 2,185,000 | 649,000 | 1,233,000 | 1,850,000 | 1,152,000 | 2,129,000 | -3,305,000 | 1,493,000 | 2,501,937 | 2,185,432 | 1,912,489 | -2,081,179 | 4,628,115 | 4,570,704 |
Employee Costs | |||||||||||||||
Number Of Employees | 2 | 3 | 3 | 2 | 3 | 3 | |||||||||
EBITDA* | 2,369,000 | 3,562,000 | 2,384,000 | 2,385,000 | 2,373,000 | 2,392,000 | 2,465,000 | 598,000 | 1,679,000 | 2,683,253 | 2,332,855 | 2,074,920 | -1,891,871 | 4,827,393 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 6,516,000 | 6,726,000 | 7,042,000 | 7,252,000 | 7,463,000 | 7,702,000 | 7,941,000 | 8,183,000 | 12,957,000 | 13,139,837 | 13,325,546 | 13,511,255 | 13,698,195 | 13,888,872 | 14,058,534 |
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | 503,000 | 18,325,000 | 5,490,179 | 4,562,598 | |||||||||||
Total Fixed Assets | 6,516,000 | 6,726,000 | 7,042,000 | 7,252,000 | 7,463,000 | 7,702,000 | 8,444,000 | 26,508,000 | 12,957,000 | 13,139,837 | 13,325,546 | 13,511,255 | 13,698,195 | 19,379,051 | 18,621,132 |
Stock & work in progress | |||||||||||||||
Trade Debtors | |||||||||||||||
Group Debtors | 32,943,000 | 30,890,000 | 28,427,000 | 26,717,000 | 25,002,000 | 23,271,000 | 21,612,000 | 19,128,000 | 30,195,000 | 28,515,554 | 25,832,301 | 23,497,277 | 21,407,120 | 18,835,950 | 15,029,104 |
Misc Debtors | 218,000 | 196,000 | 195,000 | 190,000 | 185,000 | 164,000 | 17,405 | ||||||||
Cash | |||||||||||||||
misc current assets | |||||||||||||||
total current assets | 32,943,000 | 31,108,000 | 28,623,000 | 26,912,000 | 25,192,000 | 23,456,000 | 21,612,000 | 19,292,000 | 30,195,000 | 28,515,554 | 25,832,301 | 23,497,277 | 21,424,525 | 18,835,950 | 15,029,104 |
total assets | 39,459,000 | 37,834,000 | 35,665,000 | 34,164,000 | 32,655,000 | 31,158,000 | 30,056,000 | 45,800,000 | 43,152,000 | 41,655,391 | 39,157,847 | 37,008,532 | 35,122,720 | 38,215,001 | 33,650,236 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | |||||||||||||||
Group/Directors Accounts | 14,348,000 | ||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | 779,000 | 742,000 | 707,000 | 673,000 | 643,000 | 608,000 | 586,000 | 606,000 | |||||||
other current liabilities | 227,000 | 358,000 | 461,000 | 1 | 1 | 1 | 1,009,733 | 1,089,954 | |||||||
total current liabilities | 1,006,000 | 742,000 | 707,000 | 673,000 | 643,000 | 966,000 | 1,047,000 | 606,000 | 14,348,000 | 1 | 1 | 1 | 1,009,733 | 1,089,954 | |
loans | 14,348,008 | 14,348,008 | 14,348,008 | 14,348,008 | 14,348,008 | 14,348,008 | |||||||||
hp & lease commitments | 17,299,000 | 17,342,000 | 17,387,000 | 17,428,000 | 17,467,000 | 17,496,000 | 17,473,000 | 17,463,000 | |||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | 3,578,000 | 3,583,000 | 3,589,000 | 2,730,000 | 2,445,000 | 2,446,000 | 2,438,000 | 2,438,000 | 206,000 | 202,704 | 207,097 | 243,214 | 269,892 | 271,261 | 254,390 |
total long term liabilities | 20,877,000 | 20,925,000 | 20,976,000 | 20,158,000 | 19,912,000 | 19,942,000 | 19,911,000 | 19,901,000 | 206,000 | 14,550,712 | 14,555,105 | 14,591,222 | 14,617,900 | 14,619,269 | 14,602,398 |
total liabilities | 21,883,000 | 21,667,000 | 21,683,000 | 20,831,000 | 20,555,000 | 20,908,000 | 20,958,000 | 20,507,000 | 14,554,000 | 14,550,713 | 14,555,106 | 14,591,223 | 14,617,900 | 15,629,002 | 15,692,352 |
net assets | 17,576,000 | 16,167,000 | 13,982,000 | 13,333,000 | 12,100,000 | 10,250,000 | 9,098,000 | 25,293,000 | 28,598,000 | 27,104,678 | 24,602,741 | 22,417,309 | 20,504,820 | 22,585,999 | 17,957,884 |
total shareholders funds | 17,576,000 | 16,167,000 | 13,982,000 | 13,333,000 | 12,100,000 | 10,250,000 | 9,098,000 | 25,293,000 | 28,598,000 | 27,104,678 | 24,602,741 | 22,417,309 | 20,504,820 | 22,585,999 | 17,957,884 |
Jun 2024 | Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 2,159,000 | 3,247,000 | 2,174,000 | 2,174,000 | 2,134,000 | 2,153,000 | 2,223,000 | 417,000 | 1,496,000 | 2,497,544 | 2,147,146 | 1,887,980 | -2,082,548 | 4,647,409 | |
Depreciation | 210,000 | 315,000 | 210,000 | 211,000 | 239,000 | 239,000 | 242,000 | 181,000 | 183,000 | 185,709 | 185,709 | 186,940 | 190,677 | 179,984 | 144,894 |
Amortisation | |||||||||||||||
Tax | 5,000 | 6,000 | -859,000 | -285,000 | 359,000 | -366,000 | -1,000 | -2,232,000 | -3,000 | 4,393 | 38,286 | 24,509 | 1,369 | -19,294 | -141,028 |
Stock | |||||||||||||||
Debtors | 1,835,000 | 31,108,000 | 1,711,000 | 1,720,000 | 1,736,000 | 1,341,000 | -15,502,000 | 7,422,000 | 1,679,446 | 2,683,253 | 2,335,024 | 2,072,752 | -2,901,604 | 4,734,427 | 19,591,702 |
Creditors | |||||||||||||||
Accruals and Deferred Income | 227,000 | -358,000 | -103,000 | 461,000 | -1 | 1 | -1,009,733 | -80,221 | 1,089,954 | ||||||
Deferred Taxes & Provisions | -5,000 | 3,583,000 | 859,000 | 285,000 | -1,000 | 8,000 | 2,232,000 | 3,296 | -4,393 | -36,117 | -26,678 | -1,369 | 16,871 | 254,390 | |
Cash flow from operations | 761,000 | -23,957,000 | 673,000 | 665,000 | 637,000 | 590,000 | 18,427,000 | -6,824,000 | -151 | 10,322 | |||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -14,348,000 | 14,348,000 | |||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -14,348,008 | 14,348,008 | |||||||||||||
Hire Purchase and Lease Commitments | -6,000 | 18,084,000 | -7,000 | -9,000 | 6,000 | 45,000 | -10,000 | 18,069,000 | |||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -755,000 | -1,068,000 | -666,000 | -656,000 | -643,000 | -635,000 | -93,000 | -6,000 | |||||||
cash flow from financing | -761,000 | 30,998,000 | -673,000 | -665,000 | -637,000 | -590,000 | -18,427,000 | 3,715,000 | 314 | 27,735,188 | |||||
cash and cash equivalents | |||||||||||||||
cash | |||||||||||||||
overdraft | |||||||||||||||
change in cash |
Perform a competitor analysis for elysium healthcare property 2 limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in WD6 area or any other competitors across 12 key performance metrics.
ELYSIUM HEALTHCARE PROPERTY 2 LIMITED group structure
Elysium Healthcare Property 2 Limited has no subsidiary companies.
Ultimate parent company
P HEALTH SARL
#0102578
2 parents
ELYSIUM HEALTHCARE PROPERTY 2 LIMITED
05406155
Elysium Healthcare Property 2 Limited currently has 3 directors. The longest serving directors include Ms Rebecca Gibson (Apr 2005) and Dr Quazi Haque (Mar 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Rebecca Gibson | 50 years | Apr 2005 | - | Director | |
Dr Quazi Haque | 56 years | Mar 2012 | - | Director | |
Mr Colin McCready | United Kingdom | 49 years | Jul 2023 | - | Director |
P&L
June 2024turnover
2.5m
-33%
operating profit
2.2m
-34%
gross margin
19.3%
-4.67%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
17.6m
+0.09%
total assets
39.5m
+0.04%
cash
0
0%
net assets
Total assets minus all liabilities
company number
05406155
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
March 2005
age
20
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
June 2024
previous names
partnerships in care property 13 limited (December 2016)
cinven propco 13 limited (May 2005)
accountant
-
auditor
-
address
2 imperial place, maxwell road, borehamwood, hertfordshire, WD6 1JN
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to elysium healthcare property 2 limited. Currently there are 0 open charges and 4 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELYSIUM HEALTHCARE PROPERTY 2 LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|